- Home
- APTV vs NBIX Comparison
APTV vs NBIX Comparison
Compare APTV & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | APTV | NBIX |
|---|---|---|
| Founded | 2011 | 1992 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Auto Parts:O.E.M. | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.1B | 13.9B |
| IPO Year | 2011 | 1996 |
Fundamental Metrics
Financial Performance| Metric | APTV | NBIX |
|---|---|---|
| Price | $70.96 | $131.08 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 17 | 22 |
| Target Price | $95.40 | ★ $175.27 |
| AVG Volume (30 Days) | ★ 1.9M | 799.2K |
| Earning Date | 04-30-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 41.95 |
| EPS | 0.75 | ★ 4.67 |
| Revenue | ★ $20,398,000,000.00 | $161,626,000.00 |
| Revenue This Year | $7.51 | $22.85 |
| Revenue Next Year | $4.82 | $9.99 |
| P/E Ratio | $94.63 | ★ $27.34 |
| Revenue Growth | 3.47 | ★ 977.51 |
| 52 Week Low | $47.19 | $84.23 |
| 52 Week High | $88.93 | $160.18 |
Technical Indicators
Market Signals| Indicator | APTV | NBIX |
|---|---|---|
| Relative Strength Index (RSI) | 42.76 | 51.01 |
| Support Level | $69.38 | $128.03 |
| Resistance Level | $72.22 | $136.74 |
| Average True Range (ATR) | 2.01 | 2.93 |
| MACD | 0.21 | 0.18 |
| Stochastic Oscillator | 59.72 | 72.34 |
Price Performance
Historical ComparisonAbout APTV Aptiv PLC
Aptiv PLC is an industrial technology company focused on enabling a more automated, electrified and digitalized future. The company's technologies reach from sensor to cloud, including the hardware and software necessary to support automotive and other industries on a global basis. Its Advanced Safety and User Experience segment provides advanced software and services, intelligent sensors and high-performance compute platforms; its Engineered Components Group segment provides connection systems, high-performance interconnects, and cable management and protection solutions; and its Electrical Distribution Systems segment provides low voltage and high voltage power, signal and data distribution.
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.